The agenda of the Second International Congress of Georgian Association of Oncological Urology is already known

News

 

The agenda of the Second International Congress of Georgian Association of Oncological Urology is already known, so is the list of speakers and topics on which they are going to talk and share their experience. The sections of the program are composed around the same content.

Each theme has their moderators, represented by the world’s leading specialists of the field. At the end of each section there will be a discussion and any member of the congress can participate. Generally, discussion is always one of the most interesting part of such meetings.

Once you familiarize with this program and the titles of the speakers, you will once again be convinced that the congress is represented by the world’s most famous oncologists, urologists, radiologists, who will visit Tbilisi on 26-27th of October. Do not miss this important gathering, register now!

 

 

26-Oct-18Sessions, Moderators, SpeakersDuration h/min AffiliationCountry
9:00Greetings30min
Guram Karazanashvili4President, Georgian Association of Oncological UrologyGeorgia
George Sharvashidze3Rector of Tbilisi State UniversityGeorgia
President of Rustaveli Fund3President, Rustaveli FundGeorgia
Aleksander Tsiskaridze3Deputy Rector of Tbilisi State UniversityGeorgia
Kokaia Zaal3Chairman of Society of Georgian UniversityGeorgia/Sweden
Kordzaia Dimitri3Dean of Medical School of Tbilisi State UniversityGeorgia
Luchava Lado3President, Georgian Association of OncologistsGeorgia
Hendrik Van Poppel4Adjunct Secretary General of European Association of UrologyBelgium
Christopher Evans4President, Society Urologic Oncology of USAUSA
9:30Bladder Cancer 1. Moderators: Brausi Maurizio, Necchi Andrea, Polyakov Sergey, Armen Avoian, Avtandil Imedadze1h/30min
9:30Bladder Cancer prevention program15Brausi MaurizioChairman of European Section of Oncological Urology. Ex. President Italian Society of UrologyItaly
9:45Latest data on genomics of urothelial cancer15Necchi AndreaEuropean Society of Medical Oncology, Faculty Group in Genitourinary cancersItaly
10:00Fluorescent cystoscopy-assisted TUR: does it affect outcome in NMIBC patients?15Polyakov SergeyChief, Department of Oncourology Belarusian Cancer CenterBelarus
10:15Characteristics and clinical significance of histological variants of bladder cancer15Burkadze George, Gagoshidze NikolozPresident of Georgian Association of PathologistsGeorgia
10:30Bladder sparing in muscle invasive bladder cancer: facts of fiction?15Brausi MaurizioChairman of European Section of Oncological Urology. Ex. President Italian Society of UrologyItaly
10:45Discussion15
11:00Coffee15
11:15Bladder Cancer 2. Brausi Maurizio, Necchi Andrea, Eduard Stakhovsky, Guram Karazanashvili, Ekaterine Arkania1h/45min
11:15Diagnosis and treatment of T1 high Grade TCC of the bladder : what has changed in the last years15Brausi MaurizioChairman of European Section of Oncological Urology. Ex. President Italian Society of UrologyItaly
11:30Immunotherapy in early and advanced stages of bladder cancer15Necchi AndreaEuropean Society of Medical Oncology, Faculty Group in Genitourinary cancersItaly
11:45 Peritoneum, nerve and prostate apex sparing extrapertitoneal radical cystoprostatectomy (RC) and extraperitoneal neobladder formation. J Urol Suppl Vol. 199, No. 4S, Supplement, Saturday, May 19, 201815Karazanashvili GuramPresident, Georgian Association of Oncological UrologyGeorgia
12:00Quality of life after modifiedÿunilateralÿureterocutaneostomy.ÿ15Stakhovsky OlexandrOncourology Department, Ukrainian Cancer CenterUkraine
12:15Implications for targeted therapy of bladder cancer15Necchi AndreaEuropean Society of Medical Oncology, Faculty Group in Genitourinary cancersItaly
12:30Discussion15
12:45Lunch1h
13:45Renal cell and urothelial Cancer. Moderators: Stefan Mller, Shmidinger Manuela, Vsevold Matveev, Levan Dolidze, Guliko Papuashvili1h/15min
13:45Problems and pitfalls of minimal invasive or organ preserving therapy in kidney and bladder cancer15Stefan MullerDirector, Department of Urology, University of Bonn. Ex. President German Society of UrologyGermany
14:00Surgical approaches to advanced kidney tumours15Matveev VsevoldPresident, Russian Association of Oncologic Urology. Scientific Director of N.N.Blokhin National Cancer Research Center, Chief of Oncourology Department, MoscowRussia
14:15Partial nephrectomy for upper tract urothelial carcinoma15Pikul Maxim, Stakhovsky EduardPresident, Ukrainian Association of Oncological UrologyUkraine
14:30Treatment of metastatic RCC in 201830Schmidinger ManuelaProgram Director for Renal cell carcinoma, Vienna Medical UniversityAustria
14:45Discussion15
15:00Coffee15
15:15Kidney, Adrenal, Cervical Cancer. Moderators: Vladislav Bargman, Mirzagaleb Tillyashaykhov, Sergey Fanarjyan, Samir Javad-Zada, Shota Bugianishvili, Zaal Kvirikashvili1h/30min
15:15Surgical approaches to adrenal malignancies15Bargman VladislavChief, Division of Urology, Department of Surgery, University Hospital Newark, NJUSA
15:30Laparoscopic nephrectomy: our experience15Guliev FuadChief, Department of Urology and Deputy Director of National Oncology Center of AzerbaijanAzerbaijan
15:45Renal Cell Carcinoma: Embolizaton, Cytoreductve nephrectomy, Targeted therapies15Shahsuvaryan Varujan, Melkonyan NairiHead, Department of Oncourology, National Center of OncologyArmenia
16:00Exentration at locally-spread cervical cancer15Mirzagaleb Tillyashaykhov, Nargiza ZahirovaPresident, National Cancer Center of Uzbekistan; Director, Cancer Center of UzbekistanUzbekistan
16:15Tromboprophilaxis after oncosurgical interventions15Pargalava DavidProfessor, Tbilisi Cardiovascular CenterGeorgia
16:30Discussion15
27-Oct-18Sessions, Moderators, SpeakersDuration h/minAffiliationCountry
9:00Prostate Cancer 1. Moderators: Evans Christopher, Abrahamsson Per-Anders, Zaal Kokaia, George Bochorishvili, Alexander Tavartkiladze 1h/30min
9:00Genomics and Biomarkers in Prostate Cancer15Evans ChristopherPresident, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology, University of California, Davis School of MedicineUSA
9:15Epidemiology and Risk Factors for Prostate Cancer15Abrahamsson Per-AndersProfessor, University of Lund. Ex. Secretary General of European Association of UrologySweden
9:30Prostate cancer stem cells - current status and future challenges15Kokaia ZaalDirector - Lund Stem Cell Center, Professor of Experimental Medical Research, Department of Clinical Sciences, Faculty of Medicine, University of LundSweden/Georgia
9:45Prostate cancer screening and the impact of screening recommendations15Evans ChristopherPresident, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology, University of California, Davis School of MedicineUSA
10:00Prostate cancer screening in Europe: The arguments for15Abrahamsson Per-AndersProfessor, University of Lund. Ex. Secretary General of European Association of UrologySweden
10:15Discussion15
10:30Coffee15
10:45Prostate Cancer 2. Ahlgren Goran, Bossi Alberto, Alekseev Boris, Dzneladze Andro, Zumbadze Irakli120
10:45RT and ADT for locally advanced PCa: what's new?15Bossi AlbertoHead of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute in VillejuifItaly
11:00Lymphadenectomy in Prostate Cancer: Yes, No, Maybe?15Evans ChristopherPresident, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology, University of California, Davis School of MedicineUSA
11:15Intraoperative detection of micrometastases in sentinel lymph nodes during radical prostatectomy15Alekseev BorisDeputy Director for Science in National Medical Research Center of Radiology in Moscow, Chief of Oncourology DepartmentRussia
11:30Docetaxel after surgery, radiation therapy or biochemical progression - is there a benefit?15Ahlgren GoranAssociate Professor of Urology and Senior Consultant in Urology at Skane University Hospital, Malm”Sweden
11:45Post-prostaectomy RT: adjuvant or (early-) salvage?15Bossi AlbertoHead of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute in VillejuifItaly
12:00Prostate Seed Brachytherapy - Present and Future15Frank KahmannUrologist; specialty: LDR-brachytherapy, Meoclinic, BerlinGermany
12:15Peculiarities of active surveillance in patients with PC in Georgia15George BochorishviliPresident, Geoegian Men's Health Association, Ex. Secretary General of Georgian Association of UrologyGeorgia
12:30Discussion15
12:45Lunch45
13:30Prostate Cancer 3. Moderators: Van Poppel Hendrik, De Santis Maria, Bossi Alberto, Matveev Vsevold, Karazanashvili Guram1h/45min
13:30Treatment of advanced and metastatic prostate cancer - the more, the earlier, the better?15De Santis MariaChair, Section of Interdisciplinary Genitourinary Cancer Medicine, Charite Medical University, BerlinGermany
13:45High risk Prostate Cancer: Surgery first?15Van Poppel HendrikAdjunct Secretary General of European Association of Urology, Faculty Member of the European Society of Medical Oncology Belgium
14:00Radical prostatectomy in clinically oligometastatic prostate cancer15Karazanashvili GuramPresident, Georgian Asssociation of Oncological UrologyGeorgia
14:15Any role for (local) RT in the up-front PCa metastatic patient?15Bossi AlbertoHead of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute in VillejuifItaly
14:30Cytoreductive prostatectomy in patients with metastatic prostate cancer15Matveev VsevoldPresident, Russian Association of Oncologic Urology. Scientific Director of N.N.Blokhin National Cancer Research Center, Chief of Oncourology Department, MoscowRussia
14:45Neoajuvant and adjuvant chemo-hormonal therapy in prostate cancer patients with lymph node's metastases: the results of prospective study15Alekseev BorisDeputy Director for Science in National Medical Research Center of Radiology in Moscow, Chief of Oncourology DepartmentRussia
15:00Discussion15
15:15Coffee15
15:30Prostate Cancer 4. Evans Christopher, Abrahamsson Per-Anders, De Santis Maria, Lika Katselashvili, Matitashvili Amiko60
15:30Targeting Androgen Receptor Signaling in Prostate Cancer15Evans ChristopherPresident, Society Urologic Oncology of USA. Professor and Chairman, Department of Urology, University of California, Davis School of MedicineUSA
15:45Role of GnRH Agonist vs. Antagonist vs. Orchiectomy in Management of Prostate Cancer15Abrahamsson Per-AndersProfessor, University of Lund. Ex. Secretary General of European Association of UrologySweden
16:00Is there a role for immunotherapy of prostate cancer?15De Santis MariaChair, Section of Interdisciplinary Genitourinary Cancer Medicine, Charite Medical University, BerlinGermany
16:15Discussion
16:30Closer15

 

Leave a reply